K-V Pharma (KV.A) Resubmits NDA for Gestiva to U.S. FDA (HOLX)
Tweet Send to a Friend
K-V Pharmaceutical Company (NYSE: KV.A)(NYSE: KV.B) announced today that it has been informed by Hologic, Inc. (Nasdaq: HOLX) that a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


